Physician profile
Bisma Alam
NPI 1780004895
$1,029.35
in general payments reported to CMS, 2019-2025
19 companies · $25.64 in 2025
The $25.64 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.98 · 2021: $208 · 2022: $567 · 2023: $162 · 2024: $36.70 · 2025: $25.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $206.44 | 2022-2023 | Tezspire |
| Glaxosmithkline, LLC. | $189.86 | 2020-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $129.78 | 2022 | |
| Mylan Specialty L.P. | $86.41 | 2022 | |
| United Therapeutics Corporation | $84.64 | 2021-2023 | Tyvaso |
| Grifols USA, LLC | $51.55 | 2022-2023 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $49.93 | 2022-2023 | Recarbrio, Zerbaxa, Dificid |
| Medtronic, INC. | $26.19 | 2021 | |
| Pulmonx Corporation | $25.64 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Baxter Healthcare | $23.91 | 2022 | |
| Advanced Respiratory, INC | $22.65 | 2021 | |
| Boston Scientific Corporation | $22.62 | 2022 | |
| Abiomed | $20.07 | 2024 | Impella |
| Philips North America LLC | $17.55 | 2021 | |
| Pfizer INC. | $15.00 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.99 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.78 | 2022 | |
| Mallinckrodt Hospital Products INC. | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bisma Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.